MIDATECH PHARMA
LIVE

Serial Number

79280356

Owner

Midatech Limited

Attorney

Manuel Valcarcel

Filing Date

Nov 14, 2019

Add to watchlist:

No watchlists yet
View on USPTO

MIDATECH PHARMA Trademark

Serial Number: 79280356 • Registration: 6263411

MIDATECH PHARMA is a trademark filed by Midatech Limited on November 14, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Midatech Limited (9 trademarks)

Oddfellows House,

Entity Type: 99

Trademark Details

Filing Date

November 14, 2019

Registration Date

February 9, 2021

Published for Opposition

November 24, 2020

Goods & Services

Custom manufacture of nano-particles for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders

Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; nano-particle ingredients for use in pharmaceuticals, medicines and medicated cosmetics for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders

Pharmaceutical preparations and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles

Scientific research services for others in the field of nano-particle technology; pharmaceutical and drug development and drug discovery services; scientific laboratory services, namely, testing, efficiency evaluation and advisory services in the field of nano-particles and nano-medicine; scientific laboratory services, namely, testing, efficiency and technical and scientific advisory services in the field of pharmaceuticals; scientific research laboratory services, namely, nano-particle laboratory services

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 9, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 7, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 12, 2021 FICS
FINAL DISPOSITION PROCESSED
May 12, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 9, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 9, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Dec 6, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 24, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 24, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 18, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 18, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 4, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 16, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2020 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 23, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 23, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 23, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 23, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 23, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 23, 2020 COAR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2020 TROA
REFUSAL PROCESSED BY IB
Apr 18, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 27, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Mar 17, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 12, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 11, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 11, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 5, 2020 REPR